Human serum fetuin A/α2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Kalabay, László ^a   Gráf, László ^a   Vörös, Krisztián ^a   Jakab, László ^a   Benko, Zsuzsa ^b   Telegdy, László ^b   Fekete, Béla ^a   Prohászka, Zoltán ^a,c   Füst, George ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Szent Laszlo Hospital   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 2 MACROGLOBULIN; ALPHA2 GLYCOPROTEIN; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; C REACTIVE PROTEIN; DIURETIC AGENT; FETUIN; HAPTOGLOBIN; HEMOGLOBIN; OROSOMUCOID; TRANSFERRIN; ALPHA2HS GLYCOPROTEIN; BIOLOGICAL MARKER; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; AREA UNDER THE CURVE; ARTICLE; CELL FUNCTION; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FATALITY; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; RELIABILITY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS; BLOOD; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; ROC CURVE; SURVIVAL;

BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; RISK ASSESSMENT; ROC CURVE; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 34247221983     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-15     Document Type: Article

References (20)

1. Lebreton JP Joisel F Raoult JP Lannuzel B Rogez JP Humbert G Serum concentration of human alpha2 HS glycoprotein during the inflammatory process J Clin Invest 1979 64 1118-1129 372224 90057
2. Dickson IR Poole AR Veis A Localisation of plasma α2HS glycoprotein in mineralizing human bone Nature 1975 256 430-432 10.1038/ 256430a0 49853
3. Schinke T Amendt C Trindle A Poschke O Müller-Esterl W Jahnen-Dechent W The serum protein alpha2-HS glycoprotein-fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells J Biol Chem 1996 271 20789-20796 10.1074/jbc.271.34.20789 8702833
4. Jahnen-Dechent W Schinke T Trindl A Müller-Esterl W Sablitzky F Kaiser S Blessing M Cloning and targeted deletion of the mouse fetuin gene J Biol Chem 1997 272 31496-31503 10.1074/jbc.272.50.31496 9395485
5. Srinivas PR Wagner AS Reddy LV Deutsch DD Leon MA Goustin AS Grunberger G Serum α 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level Mol Endocrinol 1993 7 1445-1455 10.1210/me.7.11.1445 7906861
6. Kalabay L Chavin K Lebreton JP Robinson KA Buse MG Arnaud P Human recombinant α 2-HS glycoprotein is produced in insect cells as a full-length inhibitor of the insulin receptor tyrosine kinase Horm Metab Res 1998 30 1-6 9503031
7. Demetriou M Binkert C Sukhut B Tenenbaum HC Dennis JW Fetuin/alpha2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist J Biol Chem 1988 271 12755-12761
8. Ohnishi T Nakamura O Arakaki N Daikuhara Y Effect of phosphorylated rat fetuin on the growth of hepatocytes in primary cultures in the presence of human hepatocyte-growth factor. Evidence that phosphorylated fetuin is a natural modulator of hepatocyte-growth factor Eur J Biochem 1997 243 753-761 10.1111/j.1432-1033.1997.00753.x 9057842
9. Jakab L Kalabay L Pozsonyi T Cseh K The effect of the α2-HS-glycoprotein on the mitogen induced lymphocyte blastic transformation and IL-2 production Acta Physiol Hung 1991 77 25-31 1950589
10. Triffitt JT Gebauer U Asthon BA Owen ME Reynolds JJ Origin of plasma α2HS-glycoprotein and its accumulation in bone Nature 1976 262 226-227 10.1038/262226a0 934340
11. Kalabay L Jakab L Fekete B Prohászka Z Benkõ Zs Telegdy L Lõrincz Zs Závodszky P Arnaud P Fekete B Human fetuin/ α2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer Eur J Gastroenterol Hepatol 2002 14 389-394 10.1097/ 00042737-200204000-00009 11943951
12. Kalabay L Prohászka Z Füst G Benkõ Zs Telegdy L Szalay F Tóth K Gráf L Jakab L Pozsonyi T Arnaud P Fekete B Karádi I Human fetuin/α2HS-glycoprotein levels in sera of patients with liver disease Liver Cirrhosis: New Research New York: Nova Science Chen TM 2005 63-75
13. Kalabay L Szalay F Nemesánszky E Telegdy L Jakab L Romics L Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis J Hepatol 1997 26 1426-1427 10.1016/ S0168-8278(97)80483-7 9210635
14. Cholongitas E Papatheodoridis GV Vangeli M Terreni N Patch D Burroghs AK Systematic review: The model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005 22 1079-1089 10.1111/ j.1365-2036.2005.02691.x 16305721
15. Christensen E Prognostic models including the Child-Pugh, MED and Mayo risk scores - where are we and where should we go? J Hepatol 2004 41 344-350 10.1016/j.jhep.2004.06.005 15288486
16. Kamath PS Wiesner RN Malinoch M Kremers W Therneau TM Kosberg CL D'Amico G Dickson ER Kim WR A model to predict survival in patients with end-stage liver disease Hepatology 2001 33 464-470 10.1053/ jhep.2001.22172 11172350
17. Daveau M Davrinche C Djelassi N Lemetayer J Julen N Hiron M Arnaud P Lebreton JP Partial hepatectomy and mediators of inflammation decrease the expression of liver α2-HS glycoprotein gene in rats FEBS Lett 1990 273 79-81 10.1016/0014-5793(90)81055-S 2226868
18. Daveau M Davrinche C Julen N Hiron M Arnaud P Lebreton JP The synthesis of human α-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells FEBS Lett 1988 241 191-194 10.1016/ 0014-5793(88)81059-7 2848721
19. Kalabay L Nemesánszky E Csepregi A Pusztay M Dávid K Horváth G Ibrányi E Telegdy L Pár A Bíró A Fekete B Gervain J Horányi M Ribiczey P Csöndes M Kleiber M Walentin Sz Prohászka Z Füst G Paradoxic alteration of acute phase protein levels in patients with chronic hepatitis C treated with interferon-α-2b Int Immunol 2004 16 51-54 10.1093/intimm/dxh024 14688060
20. Biggins SW Kim WR Terrault NA Saab S Balan V Schiano T Benson J Therneau T Kremers W Wiesner R Kamath P Klintmalm G Evidence-based incorporation of serum sodium concentration into MELD Gastroenterology 2006 130 1652-1660 10.1053/j.gastro.2006.02.010 16697729